Cargando…

Commentary on: “Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study”

Detalles Bibliográficos
Autores principales:	BRIGHT, Heber Rew, CHANDY, Sujith John, GEORGE, Renu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medical Journals Sweden, on behalf of the Society for Publication of Acta Dermato-Venereologica 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442922/ https://www.ncbi.nlm.nih.gov/pubmed/37587667 http://dx.doi.org/10.2340/actadv.v103.13348

Ejemplares similares

Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study
por: HAISMA, Marjolijn S., et al.
Publicado: (2023)

Role of Traditional Cardiovascular Risk Factors after Initiation of Statin Therapy: A PharmLines Inception Cohort Study
por: Steenhuis, Dennis, et al.
Publicado: (2022)

Sex disparities in the effect of statins on lipid parameters: The PharmLines Initiative
por: Hunt, Nicholas B., et al.
Publicado: (2022)

The effect of feedback on cardiovascular risk factors on optimization of primary prevention: The PharmLines initiative
por: van der Ende, M. Yldau, et al.
Publicado: (2020)

Impact of Drug-Gene-Interaction, Drug-Drug-Interaction, and Drug-Drug-Gene-Interaction on (es)Citalopram Therapy: The PharmLines Initiative
por: Bahar, Muh. Akbar, et al.
Publicado: (2020)

Concordance assessment of self-reported medication use in the Netherlands three-generation Lifelines Cohort study with the pharmacy database iaDB.nl: The PharmLines initiative
por: Sediq, Rahmat, et al.
Publicado: (2018)

Intercycle Unplanned Hospital Admissions Due to Cisplatin-based Chemotherapy Regimen-induced Adverse Reactions: A Retrospective Analysis
por: Bright, Heber Rew, et al.
Publicado: (2019)

Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross‐Sectional Descriptive Study as Part of the PharmLines Initiative
por: Bahar, Muh. Akbar, et al.
Publicado: (2020)

Comments on “Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study”
por: Taherifard, Erfan
Publicado: (2020)

Comment on “Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea”
por: Pottegård, Anton, et al.
Publicado: (2020)

Response to comment on “Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea”
por: Park, Eunjung, et al.
Publicado: (2020)

Folliculocystic and Collagenous Hamartoma: A Rare Cutaneous Manifestation of Tuberous Sclerosis
por: Shajil, Chandana, et al.
Publicado: (2022)

Fat pharms.
por: Ma, M
Publicado: (1996)

The technology of pharming
por: Rehbinder, Eckard, et al.
Publicado: (2009)

The paramedics’ pledge: a short commentary on its inception and development
por: Hill, Lawrence, et al.
Publicado: (2023)

The Evolution of PharmVar
por: Gaedigk, Andrea, et al.
Publicado: (2018)

Legal problems of pharming
por: Rehbinder, Eckard, et al.
Publicado: (2009)

Hydrochlorothiazide: A savior to the heart or a foe to the skin?
por: Kumar, Ayush, et al.
Publicado: (2022)

Is non-cardiac death increased with an initial invasive revascularization strategy? Commentary on the ISCHEMIA trial
por: Rodriguez, Alfredo E, et al.
Publicado: (2022)

Differences in the cytogenetic underpinnings of AL amyloidosis among African Americans and Caucasian Americans
por: Staron, Andrew, et al.
Publicado: (2022)

ECOLOGY AND WILDLIFE: Pharmed Fish
por: Betts, Kellyn S.
Publicado: (2009)

Royal College of Surgeons of England
por: Rew, Horace H.
Publicado: (1943)

PharmGED: Pharmacogenetic Effect Database
por: Zheng, C. J., et al.
Publicado: (2007)

Cell Engineering and Molecular Pharming for Biopharmaceuticals
por: Abdullah, M.A, et al.
Publicado: (2008)

Introduction of APCs in J. Young Pharm.
por: Mueen, Ahmed KK
Publicado: (2012)

My Vision: J Young Pharm
por: Parasuraman, S
Publicado: (2012)

Effects of Telmisartan with Hydrochlorothiazide versus Valsartan with Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension
por: Marfatia, Ravi, et al.
Publicado: (2012)

Never-smoker African–American women suffer more from COPD compared with never-smoker Caucasian women
por: Sumon, Mahbubur, et al.
Publicado: (2020)

Commentary: The inception of collagen cross-linking for late-onset bleb leaks - The journey and way forward
por: Ramesh, Prasanna V, et al.
Publicado: (2023)

Melanoma in Buckinghamshire: Data from the Inception of the Skin Cancer Multidisciplinary Team
por: Cubitt, J. J., et al.
Publicado: (2013)

Hydrochlorothiazide Use and Risk of Nonmelanoma Skin Cancers: A Biological Plausibility Study
por: Bigagli, Elisabetta, et al.
Publicado: (2021)

Pharm D: A new concept in India
por: Deshpande, Prasanna R., et al.
Publicado: (2012)

Pharmacogenomics Clinical Annotation Tool (PharmCAT)
por: Sangkuhl, Katrin, et al.
Publicado: (2019)

Preventing hospital admissions by reviewing medication (PHARM) in primary care: design of the cluster randomised, controlled, multi-centre PHARM-study
por: Leendertse, Anne J, et al.
Publicado: (2011)

Thermal-based early breast cancer detection using inception V3, inception V4 and modified inception MV4
por: Al Husaini, Mohammed Abdulla Salim, et al.
Publicado: (2021)

Telmisartan/hydrochlorothiazide-induced hepatotoxicity
por: Lorena, Marco, et al.
Publicado: (2015)

Hydrochlorothiazide: Hypocalcaemia: case report
Publicado: (2020)

Pharmaceutical Quality, Team Science, and Education Themes: Observations and Commentary on a Remarkable AAPS PharmSciTech Theme Issue
por: Hussain, Ajaz S., et al.
Publicado: (2021)

Radiation therapy advanced practice – commentary
por: Cox, Jenny
Publicado: (2013)

Authors’ response to Graham Rook’s commentary
por: Parker, William, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kd19n5oidilcn3472hstd7740o